Financial Highlights
Management performance overview
(First Quarter of the Fiscal Year Ending March 31, 2027)
In the first quarter of the fiscal year ending March 31, 2027, Sysmex achieved substantial year-on-year growth in both sales and profits, driven by solid performance across all regions—including particularly strong growth in the Americas—as well as the positive impact of the weaker yen.
Net sales grew 23.6% year on year, while operating profit rose 39.5% and profit attributable to owners of the parent surged 90.9%. By destination, in addition to strong sales of hematology and hemostasis instruments in the Americas, Sysmex saw growth in the EMEA, AP, and Japan regions, more than offsetting the decline in China stemming from healthcare reform. Higher sales also pushed up gross profit, contributing to the improvement in earnings.
In the second quarter and beyond, the Company will continue to accelerate the expansion of its hemostasis business in Europe and the United States, further grow its business in emerging markets, and optimize its business portfolio to enhance both growth and profitability.
- ※The figures for Q2 are the cumulative totals for Q1 and Q2.
- ※The figures for Q3 are the cumulative totals for Q1 through Q3.
- Please note that if corrections to financial results or reports are made, the data presented here may not be updated immediately.
- Please note that even in the event of a stock split or similar corporate action, retroactive adjustments to related metrics are not made.
- Please note that the update frequency may change due to revisions to the financial results report format or other reasons.
This data is prepared based on financial result reports.
While we exercise due care in converting data for publication, please note that errors may occur due to unauthorized tampering by third parties, mechanical defects caused by equipment malfunction, or other circumstances beyond our control.
For further details on financial results and related information, please refer to our financial results reports and other relevant materials.
The content on this page is provided by Takara Printing Co.Open a new window, Ltd.